Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$2.06M Sell
43,709
-6,946
-14% -$369K 4.52% 10
2015
Q2
$2.75M Sell
50,655
-2,679
-5% -$150K 4.68% 10
2015
Q1
$2.92M Sell
53,334
-10,885
-17% -$616K 4.75% 10
2014
Q4
$3.48M Sell
64,219
-13,137
-17% -$732K 4.49% 10
2014
Q3
$4.38M Sell
77,356
-2,238
-3% -$126K 4.38% 11
2014
Q2
$4.39M Buy
79,594
+258
+0.3% +$14.1K 4.13% 12
2014
Q1
$4.3M Sell
79,336
-13,890
-15% -$719K 4.35% 11
2013
Q4
$4.45M Sell
93,226
-5,209
-5% -$238K 4.35% 11
2013
Q3
$4.47M Sell
98,435
-474
-0.5% -$21.6K 4.07% 11
2013
Q2
$4.38M Buy
+98,909
New +$4.42M 4.11% 11

Other funds holding MRK

Lakeshore Capital's MRK Position: Q3 2015 in Review

Lakeshore Capital reduced its Merck (MRK) stake by 14% in Q3 2015, selling an estimated $369K and leaving 43,709 shares worth $2.06M. The position accounts for 4.52% of the portfolio, ranked #10.

Lakeshore Capital first reported a position in MRK in Q2 2013 and has held it in 10 quarters since. The position peaked at $4.47M in Q3 2013. 1,673 funds tracked by Wall St. Rank hold MRK as of Q3 2015.

  • Lakeshore Capital held 43,709 shares of Merck worth $2.06M as of Q3 2015.
  • Lakeshore Capital sold 6,946 Merck shares in Q3 2015, an estimated $369K.
  • Merck made up 4.52% of Lakeshore Capital's portfolio in Q3 2015, its #10 holding.
  • Lakeshore Capital first reported a position in Merck in Q2 2013 and has held it in 10 quarters since.
  • Lakeshore Capital's Merck position peaked at $4.47M in Q3 2013.
  • 1,673 funds tracked by Wall St. Rank held Merck as of Q3 2015.

Based on Lakeshore Capital's 13F filing for Q3 2015, filed 12 Nov 2015.